Global Neurostimulation Technologies Market Report 2021: Market Expected to Reach $9.8 Billion by 2026 from $7.1 Billion in 2021, at a CAGR of 6.9%
Dublin, May 21, 2021 (GLOBE NEWSWIRE) -- The "Global Neurostimulation Technologies Market 2021-2026" report has been added to ResearchAndMarkets.com's offering.
The global neurostimulation devices market should reach $9.8 billion by 2026 from $7.1 billion in 2021 at a compound annual growth rate (CAGR) of 6.9% for the forecast period of 2021 to 2026.
The spinal cord stimulation (SCS) devices segment of the global neurostimulation devices market is expected to grow from $2.3 billion in 2021 to $2.7 billion in 2026 at a CAGR of 3.4% for the forecast period of 2021 to 2026.
The deep brain stimulation (DBS) devices segment of the global neurostimulation devices market is expected to grow from $1.2 billion in 2021 to $2.1 billion in 2026 at a CAGR of 12.8% for the forecast period of 2021 to 2026.
This report aims to provide a comprehensive study of the global market for neurostimulation technologies/devices. It provides a detailed description of the different types of neurostimulation technologies/devices (invasive and noninvasive) and their current and historical market revenues.
Neurostimulation technologies/devices include spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, hypoglossal nerve stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation and others.
This report also covers a detailed study of therapeutic applications of neurostimulation technologies/devices including chronic pain, Parkinson's disease, epilepsy, urinary and fecal incontinence, obstructive sleep apnea, essential tremor, obsessive compulsive disorder, major depressive disorder/clinical depression and others. An in-depth analysis of the global market for neurostimulation technologies/devices includes historical data and market projection on sales by, device type, therapeutic applications and region.
For in-depth understanding of the market, profiles of market participants, key marketed devices, competitive landscape, key competitors, and their respective market shares have been provided. This report also discusses driving and restraining factors of the global neurostimulation technology/devices market.
The Report Includes:
An overview of the global markets and technologies for neurostimulation
Estimation of the market size and analyses of market trends, with data from 2020, estimates for 2021 and projection of CAGR through 2026
Description of Dorsal Root Ganglion (DRG) neurostimulator system and discussion on approved indications of stimulation therapy for various diseases
Information on recent therapy improvements and new indications for use, and discussion on alternatives to traditional stimulation therapies
Coverage of ongoing scientific discoveries and technological advances in neurostimulation technologies and insights into marketed and pipeline (R&D) products, product recalls and reimbursement policies
Market share analysis of neurostimulation devices by application, type and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges and opportunities affecting market growth
Details about symptoms, progression and epidemiology of COVID-19 and discussion on impact of COVID-19 pandemic on medical industry as well as on neurostimulation market
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
Comprehensive company profiles of major players of the industry, including Abbott Laboratories, Boston Scientific, Medtronic PLC, NeuroMetrix, NeuroSigma and Soterix Medical Inc.
Key Topics Covered:
Chapter 1: Introduction
Study Goals and Objectives
Scope of This Report
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
Chapter 2: Summary and Highlights
Chapter 3: Market and Technology Background
Introduction to Neurostimulation
Types of Neurostimulation Technologies
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation
Hypoglossal Nerve Stimulation
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation (TMS)
Others
Therapeutic Applications for Neurostimulation Technologies/Devices
Chronic Pain Management
Neurological Disorders
Urinary and Fecal Incontinence
Obstructive Sleep Apnea
Chronic Migraine and Headache
Cardiovascular Diseases
Gastrointestinal Disorders
Obesity
Psychiatric Disorders
Technology Developments
MRI Compatibility
Rechargeable and Non-rechargeable Devices
Chapter 4: Market Breakdown by Technology/Device Type
Global Market for Neurostimulation Devices by Type
Spinal Cord Stimulation (SCS) Devices
Transcutaneous Electrical Nerve Stimulation (TENS) Devices
Deep Brain Stimulation (DBS) Devices
Sacral Nerve Stimulation (SNS) Devices
Vagus Nerve Stimulation (VNS) Devices
Hypoglossal Nerve Stimulation (HGNS) Devices
Transcranial Magnetic Stimulation (TMS) Devices
Chapter 5: Market Breakdown by Region
Chapter 6: Market Breakdown by Application
Global Market for Neurostimulation Devices by Therapeutic Application
Chronic Pain
Urinary and Fecal Incontinence
Parkinson's Disease
Epilepsy
Obstructive Sleep Apnea (OSA)
Essential Tremor
Major Depressive Disorder (MDD)/Clinical Depression
Obsessive Compulsive Disorder (OCD)
Chapter 7: Key Marketed Products and Technologies
Recent Therapeutic Improvements and New Indications
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation
Hypoglossal Nerve Stimulation
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Other Types of Stimulation
New Indications and Neurostimulation Therapies
Chapter 8: Competitive Landscape
Company Market Shares by Product Segment
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Hypoglossal Nerve Stimulation Devices
Transcranial Magnetic Stimulation Devices
Transcutaneous Electrical Nerve Stimulation Devices
Recent Industry Activities
Chapter 9: Market Dynamics
Chapter 10: Impact of COVID-19
Chapter 11: Company Profiles
Abbott Laboratories
Aleva Neurotherapeutics SA
Avery Biomedical Devices Inc.
Axonics Modulation Technologies Inc.
Bioinduction Ltd.
Bioness Inc.
Biowave Corp.
Boston Scientific Corp.
Brainsway Ltd.
Cochlear Americas
CVRX Inc.
Electrocore Inc.
Inspire Medical Systems Inc.
Integer Holdings Corp.
Laborie Inc.
LivaNova plc
Mag & More GmbH
Magstim Inc.
Medtronic plc
Nalu Medical Inc.
Neuromed Consulting Inc.
Neurometrix Inc.
Neuronetics Inc.
Neuropace Inc.
Neurosigma Inc.
Neurovalens Ltd.
Nevro Corp.
Nexstim plc
Nyxoah SA
Respicardia Inc.
Soterix Medical Inc.
Stimwave LLC
Synapse Biomedical Inc.
Tonica Elektronik A/S
Xavant Technology (Pty) Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/lai2by
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900